Instrument Inactif

Communiqués Sarepta Therapeutics Inc Nasdaq

Actions

US0023461041

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

21/06	Mise à jour sectorielle : Les actions du secteur de la santé gagnent en fin d'après-midi	MT
21/06	Le S&P et le Nasdaq en légère baisse, alors que Nvidia recule pour la deuxième journée	RE

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Sarepta Therapeutics, Ryan Specialty rise; Autodesk, Trump Media fall, Friday, 6/21/2024	21/06	AQ
Sarepta Therapeutics Announces Expanded US FDA Approval of ELEVIDYS to Duchenne Muscular Dystrophy Patients Ages 4 and Above	20/06	BU
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	31/05	BU
Sarepta Therapeutics : P.413-251 Seo et al. In situ biodistribution & localization of SRP-9003 in LGMD2ER4 Mice	10/05	PU
Sarepta Therapeutics - Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health	06/05	AQ
Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health	03/05	BU
Sarepta Therapeutics: Q1 Earnings Snapshot	01/05	AQ
Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments	01/05	BU
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	01/05	BU
Sarepta Therapeutics to Announce First Quarter 2024 Financial Results	24/04	BU
REGENXBIO And Sarepta Agree To Stay Litigation Pending Outcome Of Sarepta's IPR Petition	04/04	AQ
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - March 29, 2024	01/04	AQ
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	29/03	BU
Sarepta Therapeutics Announces Call for Applications for the 2024 LGMD Grant Award Program	20/03	AQ
Sarepta Therapeutics to Present at Upcoming Investor Conferences	04/03	BU
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)	01/03	AQ
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	01/03	BU
Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program	29/02	BU
Sarepta Therapeutics: Q4 Earnings Snapshot	28/02	AQ
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments	28/02	BU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Sarepta Therapeutics Inc Nasdaq

Actions

US0023461041

Communiqués

Filtres